Skip to main content


Health

During a phase one clinical trial of a new treatment for MS patients, researchers were able to curtail the body's attacks on myelin by 50 to 75 percent, while sustaining the functionality of the rest of the immune system.
454 of 1663




Newsletter Sign Up

Saint of the Day

March 5 Saint of the Day

St. John Joseph of the Cross
March 5: St. John Joseph of the Cross was born about the middle of ... Read More